Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

CEO Corner

Information.  Access. Accountability.

Thomas K Equels, M.S., J.D.

Executive Vice Chairman, Chief Executive Officer & President
July 29, 2024 –
Early Stage Triple Negative
Breast Cancer
July 3, 2024 –
         Corporate and Clinical Update
April 25, 2024 –
          Metastatic Pancreatic Cancer 
April 18, 2024 –
Locally Advanced Pancreatic Adenocarcinoma
April 11, 2024 –
Top-line Interim Data from Recurrent Ovarian Cancer Study
March 22, 2024 –
Virtual Investor Lunch Break:
The AIM Opportunity
March 20, 2024 –
Ovarian Cancer
March 13, 2024 –
Oncology Overview
March 7, 2024 –
Welcome to the AIM CEO Corner

Topics For Tom